On August 11, 2026, the Trump administration directed CMS to bar federal Medicaid and CHIP funds from covering gender-affirming surgeries and hormone treatments for those under 19, with the rule effective October 13 and existing hormone coverage phased out by April 2027. The policy preserves mental health coverage and aligns with existing bans in at least 27 states. It was implemented via a final rule citing studies on risks and lack of benefits, with President Trump stating he directed CMS Administrator Dr. Mehmet Oz.